Tissue Plasminogen Activator for Acute Ischemic Stroke

Division of Chronic Disease Control and Community Intervention. Cardiovascular disease surveillance: stroke, 1980-1989. Atlanta: Centers for Disease Control and Prevention, 1994.

10.1016/0022-510X(89)90060-9

10.1002/ana.410320113

10.1161/01.STR.7.2.135

Meyer JS, Gilroy J, Barnhart J. Therapeutic thrombolysis in cerebral thromboembolism: randomized evaluation of intravenous streptokinase. In: Siekert W, Whisnant JP, eds. Cerebral vascular diseases. New York: Grune & Stratton, 1965:200-13.

10.1161/01.STR.23.5.632

10.1161/01.STR.23.5.641

10.2307/2531989

Mahoney FI, 1965, Md State Med J, 14, 61

10.1161/01.STR.23.1.3

10.1161/01.STR.19.5.604

10.1136/jnnp.41.7.603

10.3171/jns.1993.78.4.0537

10.1161/01.STR.25.11.2220

10.1161/01.STR.25.9.1746

Lyden PD, Broderick J, Mascha E. Reliability of the Barthel Index used for the NINDS t-PA Stroke Trial. In: Yamaguchi T, Mori E, Minematsuk K, del Zoppo GJ, eds. Thrombolytic therapy in acute stroke III. Tokyo, Japan: Springer-Verlag (in press).

Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 2nd ed. Littleton, Mass.: PSG Publishing, 1985.

10.2307/2289671

10.2307/2531248

10.2307/2336502

10.2307/2530245

10.1093/biomet/67.3.651

10.1093/biomet/69.3.661

10.1161/01.STR.24.7.1000

Mori E, 1992, Neurology, 42, 976, 10.1212/WNL.42.5.976

10.1001/jama.274.13.1017

10.1016/S0140-6736(95)91179-0

10.1016/S0140-6736(95)92689-5

1994, Lancet, 343, 311, 10.1016/S0140-6736(94)91161-4

10.1126/science.3934754

10.1161/01.STR.25.2.291